VIP Exclusive
PVC Pharmacovigilance Certification VIP Practice Exam
PVC — This exam mirrors the Pharmacovigilance Certification (PVC) assessments administered by professional bodies such as the Drug Information Association (DIA), TOPRA, and aligned with EMA Good Pharmacovigilance Practice (GVP) modules and ICH E2A–E2F guidelines; no single globally standardized 'PVC' exam exists, so this is a comprehensive original practice set reflecting the core knowledge domains tested across leading PV certification programs.
30
Questions
90m
Time Limit
75.00%
To Pass
Question 1 of 30👑 VIP
A pharmacovigilance professional at a marketing authorization holder (MAH) receives a spontaneous report from a healthcare professional describing a patient who experienced sudden-onset agranulocytosis two weeks after initiating treatment with a newly approved antipsychotic. The event resulted in hospitalization for 10 days. Under ICH E2A criteria, which combination of seriousness criteria applies to this case, and what is the maximum expedited reporting timeline to the relevant competent authority?
Questions 2–30 and full explanations are VIP-exclusive.